Cargando…
FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas
BACKGROUND: Although FGF 19 gene aberrations are associated with carcinogenesis and progression in human cancers, the roles of FGF 19 genetic amplification and expression in Chinese patients with lung squamous cell carcinoma (LSCC) and FGF 19 amplification as a potential therapeutic target for LSCC...
Autores principales: | Zhang, Xiaochen, Kong, Mei, Zhang, Zhen, Xu, Suzhen, Yan, Feifei, Wei, Liyuan, Zhou, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668513/ https://www.ncbi.nlm.nih.gov/pubmed/28906590 http://dx.doi.org/10.1111/1759-7714.12504 |
Ejemplares similares
-
Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2‐FGFR1 autocrine loop
por: Cen, Mengyuan, et al.
Publicado: (2018) -
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022) -
Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma
por: Zhang, Nana, et al.
Publicado: (2019) -
MiR‐372‐3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma
por: Wang, Qing, et al.
Publicado: (2017) -
FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy
por: Zhang, Yanshuang, et al.
Publicado: (2022)